Literature DB >> 3104466

The role of the T cell receptor, CD8, and LFA-1 in different stages of the cytolytic reaction mediated by alloreactive T lymphocyte clones.

D Blanchard, C van Els, J Borst, S Carrel, A Boylston, J E de Vries, H Spits.   

Abstract

The cytotoxic reaction mediated by cytotoxic T lymphocytes (CTL) consists of three phases: first, the CTL binds to the target cell; next, the CTL is triggered to lyse the target cell; and in the third phase, the CTL detaches from the target cell which is lysed in the absence of the CTL. Recently, we obtained evidence that human alloreactive CTL clones initially adhere to target cells without the involvement of the interaction between the T cell receptor (Tcr) and its specific target antigen. In the present study, we investigated the effect of monoclonal antibodies specific for the Tcr on the cytotoxic reaction of three CD8+ HLA-A2-specific CTL clones, using a single cell assay in which the binding event can be distinguished from the post-binding (lytic) phase of the cytolytic reaction. It was found that monoclonal antibodies directed at a variable part of the Tcr do not affect the binding phase but strongly block the lytic phase of the cytotoxic reaction. An anti-constant region Tcr antibody and an anti-CD3 reagent had a similar effect on the two phases of the reaction as the anti-variable part Tcr antibodies. In contrast, antibodies specific for LFA-1 strongly blocked the adhesion phase but did not affect the lytic phase. Antibodies specific for CD-8 had intermediate effects. They could block both the adhesion as well as the lytic phase. The effect of anti-CD8 appeared to be dependent on the CTL clone tested. One clone was found to be inhibited in the adhesion phase, but not in the lytic phase, whereas anti-CD8 hardly blocked the adhesion phase of two other CTL clones, but affected the lytic step of those clones. Our data indicate that LFA-1 is a major adhesion molecule in the CTL reaction, whereas the Tcr/CD3 complex is implicated in a phase after the initial formation of conjugates. CD8 is associated with both steps in the cytolytic reaction. In addition to its minor role in the adhesion phase, our data suggest strongly that CD-8 is involved in the triggering phase of the cytolytic reaction.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3104466

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Clonal analysis of CD4+/CD8+ T cells in a patient with aplastic anemia.

Authors:  U Moebius; F Herrmann; T Hercend; S C Meuer
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

2.  Requirements for the construction of antibody heterodimers for the direction of lysis of tumors by human T cells.

Authors:  C F Scott; W A Blättler; J M Lambert; R S Kalish; C Morimoto; S F Schlossman
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

3.  Regulation of clonal growth by anti-T-cell receptor antibody-directed lysis.

Authors:  P De Berardinis; M Londei; S Carrel; M Feldmann
Journal:  Immunology       Date:  1988-07       Impact factor: 7.397

4.  Inhibition of recall responses through complementary therapies targeting CD8+ T-cell- and alloantibody-dependent allocytotoxicity in sensitized transplant recipients.

Authors:  Jason M Zimmerer; Phillip H Horne; Lori A Fiessinger; Mason G Fisher; Kartika Jayashankar; Sierra F Garcia; Mahmoud Abdel-Rasoul; Nico van Rooijen; Ginny L Bumgardner
Journal:  Cell Transplant       Date:  2012-10-11       Impact factor: 4.064

5.  Interaction of CD4 with HLA class II antigens and HIV gp120.

Authors:  D Piatier-Tonneau; L N Gastinel; F Amblard; M Wojcik; P Vaigot; C Auffray
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

6.  Prevention of adoptive transfer of murine Sjögren's syndrome into severe combined immunodeficient (SCID) mice by antibodies against intercellular adhesion molecule-1 (ICAM-1) and lymphocyte function-associated antigen-1 (LFA-1).

Authors:  Y Hayashi; N Haneji; K Yanagi; H Higashiyama; H Yagita; H Hamano
Journal:  Clin Exp Immunol       Date:  1995-11       Impact factor: 4.330

7.  In vitro modulation of leucocyte-function-associated antigen-1 expression on two leukemic cell lines.

Authors:  A Altmeyer; C Moog; C Waltzinger; G Hauptmann; P Bischoff
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

8.  Direct evidence for binding of CD8 to HLA class I antigens.

Authors:  Y Rosenstein; S Ratnofsky; S J Burakoff; S H Herrmann
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

9.  Functional consequences of anti-sense RNA-mediated inhibition of CD8 surface expression in a human T cell clone.

Authors:  J E Hambor; M L Tykocinski; D R Kaplan
Journal:  J Exp Med       Date:  1988-10-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.